Second hits in POLE have been reported (Cancer Genome Atlas Network) (1,18–21) in some CRC tumours which could imply a tumour suppressor activity of the gene but the question whether POLE act as a classical tumour gene is not yet clear. This evidence concerns the gene POLE and colorectal carcinoma.